Today is the last opportunity to lodge expressions of interest to attend the AusMedtech Mission to China 2016, to be held over nine days (28 February - Monday 7 March).
The tailored and highly-flexible to delegate needs visit will support Australian medtech companies to consider their options when engaging in and with Chinese interests.
The mission will have many optional components and offer two main steams: (1) for first-time visitors to China who are interested in an in-country introduction; and (2) for companies and individuals experienced in China and ready to find partners, such as distributors or investors.
The mission plans to visit Tianjin (2 nights), Beijing (3 nights), Nanjing (1 night) and Shanghai (3 nights). The draft agenda is available at the AusBiotech website.
AusBiotech will lead the mission. There is no participation charge for medtech companies or AusBiotech members and all attendees will cover their own costs. Cost information will be confirmed in late November 2015.
The mission is part of the larger ‘Australian Medical Devices & Diagnostics to China’ project that aims to facilitate medical devices and diagnostics trade and partnership with China by breaking down the major barriers for Australian companies. This activity is supported with funding from the Australian Trade Commission as part of the Asian Business Engagement (ABE) Plan*.
Stream 1 will be exploratory in nature and provide an initial understanding for medtech companies doing business in China, including:
- Business etiquette and cultural protocols;
- Business structure options;
- Path to registration of medical devices;
- General introductory briefings and meetings with Government officials.
Stream 2 will offer briefing updates as well as tailored meeting services for those seeking more personalised visits and interactions, for companies ready to find a partner, ink a deal or seeking more detailed information.
There will be a number of sections of the program that are common to both streams. Participants are welcome to join for part or the entire program.
The objective of the mission is to build on the information provided in the Guide for Australian medical technology companies seeking to engage in China, and AusBiotech’s workshops and China Directory to support Australian medtech companies with information to enable them to assess and (if appropriate) take opportunities to engage in and with China.
Those who express interest by today will be invited to a pre-mission briefing 26 November 2015.
Please forward your expression of interest to AusBiotech Chief Industry Affairs Officer, Lorraine Chiroiu (firstname.lastname@example.org 0429 801 118/03 9828 1414) by COB 10 November 2015. Enquires are also welcome.
*The views expressed herein are not necessarily the view of the Commonwealth of Australia, and the Commonwealth does not accept responsibility for any information or advice contained herein.
The overall project is to be delivered via AusBiotech’s AusMedtech, the national industry group that represents the medical technology sector and is supported by in-kind support from major partners FB Rice and Deloitte.